Longtime U.S. Senator Lindsey Graham of South Carolina died this weekend at the age of seventy-one. According to the coroner’s report, Senator Graham died of aortic dissection and heart disease. Senator Graham had just returned from a trip to Ukraine, fueling speculation about potential foul play, but no evidence to support those rumors is currently known.

Under South Carolina law, the Governor may appoint a replacement to serve out the remainder of Senator Graham’s term, which ends in January 2027. At the same time, the Republican Party of South Carolina will have until August to hold a primary and nominate a new candidate for the 2026 midterm elections. 

Senator Graham’s untimely death will likely have an impact on the 2026 midterm elections and the balance of power in Congress for the rest of this year. His passing temporarily reduces the Republican conference to 51 senators, making it more difficult for Senate Majority Leader John Thune to advance legislation. With fewer votes available, Republican leaders have less room for defections within their own party, increasing the leverage of individual senators during negotiations on major legislation…

Energy giants like Exxon and Chevron have been buying up land in America’s lithium hotspot. Now they’ve got a new neighbor. EnergyX just acquired 35,000 gross acres of high-grade lithium resources in the Smackover Formation, right next to Exxon and Chevron’s projects.

What’s really turning heads about this move is that EnergyX isn’t just competing for lithium-rich land. Their patented technology can extract up to 3X more lithium than traditional methods. That combination positions EnergyX to be one of the biggest lithium producers in America. Plus, General Motors has already invested along with other global leaders like Eni and POSCO.*

Great timing too, because the demand for lithium is projected to grow 5X by 2040. You can claim a stake in the lithium boom too. Invest in EnergyX.

In addition to Senator Graham’s death, U.S. Senator Mitch McConnell has been hospitalized for several weeks due to a fall and pneumonia. Senator McConnell, who is eighty-four years old, has suffered from declining health for several years and has not been present in Congress since June. McConnell’s illness and the death of Senator Graham reduce the Republican majority in the Senate even further. The narrow margins will likely increase political pressure on any new legislation brought forward for the rest of 2026.

South Carolina law requires the governor to appoint an interim senator until a special election is held. Senator Graham would likely have easily won reelection in November, and though his death has put the outcome of that race in doubt, it is likely whoever Republicans nominate to replace him will still be the favorite to win in November. South Carolina has long been a Republican dominated state and that is likely to continue going forward.

During more than two decades in the Senate, Senator Graham became one of Congress’s leading advocates for a strong U.S. military, increased defense spending, support for Ukraine, and close strategic partnerships with Israel and NATO allies. As chairman of the Senate Budget Committee, he also played an important role in shaping Republican fiscal priorities. His death leaves a significant leadership void within the Republican caucus and may alter the direction of congressional debates on foreign policy and national security until a successor emerges.

Lindsey Graham’s death represents the loss of one of the Senate’s most experienced and influential Republican lawmakers. While information about Senator McConnell’s health was slow to be made public, Senator Graham’s autopsy results were available less than two days after his passing, a marked contrast with the slowness of reporting on Senator McConnell. 

Passing new budgetary, defense, or other legislation will likely be more difficult now for Republicans because of their diminished majority in Congress. 

*Disclaimer: Energy Exploration Technologies, Inc. (“we”, “us”, “our”, and “EnergyX” is conducting an offering of securities pursuant to Regulation A of the Securities Act of 1933, as amended. An offering statement covering this offering has been qualified by the U.S. Securities and Exchange Commission (the “SEC”). Neither this communication nor any of its content constitutes an offer to sell, solicitation of an offer to buy or a recommendation for any of our securities by our company or any third party. Offers and sales of the securities are being made solely by means of the qualified offering circular. Investing in our securities involves significant risks. Before investing, you should consult with your financial advisor, accountant, and/or attorney legal, and carefully review the qualified offering circular (including the “Risk Factors” section) and any offering circular supplements.

The most recent qualified offering circular is available at https://www.sec.gov/Archives/edgar/data/1830166/000149315226017123/form253g2.htm. The most recent qualified offering circular and any supplements can also be found on the SEC’s EDGAR filing database, available at www.sec.gov/edgar/search/. Prospective investors should note that neither the SEC nor any federal or state securities commission or regulatory authority has approved or recommended our securities or determined that our offering circular is truthful or complete. Any representation to the contrary is unlawful. We are not a broker-dealer or investment adviser registered under the Securities Exchange Act of 1934 or the Investment Advisers Act of 1940. No communication made by us or any of our affiliates, through this communication or any other medium, should be construed as a recommendation to purchase, sell, or hold any securities, or as investment, tax, financial, accounting, legal, regulatory, or compliance advice. Neither this communication nor any of its content constitutes an offer to sell, solicitation of an offer to buy or a recommendation for any of our securities by our company or any third party. The content presented here is provided for general information purposes only and is not intended to solicit the purchase of securities or to be used as investment, legal or tax advice. Statement Regarding Forward-Looking Statements The information presented herein may include forward-looking statements, estimates, or projections regarding our anticipated future performance. If present, these statements are subject to risks, uncertainties, and assumptions. In some cases, you can identify these statements by forward-looking words such as “may”, “might”, “will”, “should”, “expect”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “future” or “continue”, the negative of these terms, and other comparable terminology. Such forward-looking statements are based on current plans, estimates and expectations and are made pursuant to the Private Securities Litigation Reform Act of 1995. These statements, estimates and projections, if any, are based upon various assumptions made concerning our anticipated results and industry trends, which may or may not occur. We are not making any representations as to the accuracy of any such forward-looking statements, estimates or projections. Our actual performance may be materially different from any such statements, estimates or projections. We are under no duty to update any of these forward-looking statements to conform them to actual results or revised expectations.